Search

everythinglearnresearchcommunity

for

Search:↓

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Presurgical models can effectively and affordably screen cancer prevention agents.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Adding a second method to PROTACs could improve cancer treatment.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Reporter characteristics affect detection of hair loss from cancer therapy.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Both estrogens and androgens are important for health in both males and females.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.